14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 25 Jun 2024

AVEO Predictions History

3 years ago
JS predicted that AVEO for 2021-03-18 is going $10.93 (7.37%)

3 years ago
jjsheets330 predicted that AVEO for 2021-03-18 is going $23.00 (106.83%)

3 years ago
evan.allen001.219860 predicted that AVEO for 2021-03-18 is going $15.00 (34.89%)

Rank:

3 years ago
JS predicted that AVEO for 2020-10-13 is going $6.34 (-0.31%)

3 years ago
iHustle84 predicted that AVEO for 2020-10-13 is going $6.90 (8.49%)

3 years ago
sander7100 yo bro predicted that AVEO for 2020-09-11 is going $5.85 (8.13%)

3 years ago
JS predicted that AVEO for 2020-09-11 is going $5.87 (8.50%)

3 years ago
iHustle84 predicted that AVEO for 2020-09-11 is going $5.40 (-0.18%)

3 years ago
تراحيب العتيبي predicted that AVEO for 2020-09-11 is going $9.00 (54.64%)

Rank:

4 years ago
JS predicted that AVEO for 2020-05-26 is going $9.47 (0.00%)

Click to get the best stock tips daily for free!

About AVEO Pharmaceuticals

AVEO Pharmaceuticals AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the treatment of RCC, HCC, immunologically cold tumors, and CCA. The company has also completed a Phase II ... AVEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT